Blastoactiva is the first skin cell repair cream with double A select centella asiatica

• Almirall enhances it dermatology area with a new dermopharmaceutical product to activate, repair and renew aggravated skin

  Barcelona, 22 September 2009.- This autumn a new product from Almirall's dermatology areawill be launched onto the pharmaceutical market: Blastoactiva. Blastoactiva is the first skin cell repair cream with double A select centella asiatica to activate, repair and renew aggravated skin.  The dermopharmaceutical product's exclusive formula comes from centella asiatica cultivated in Madagascar under strict scientific controls to ensure a high concentration of the purest and most effective active ingredients.  A rigorous extraction process obtains two active ingredients selected from the centella asiatica: asiatic acid and asiaticoside, giving rise to the name double A select.   Blastoactiva revitalises cells and stimulates renewal of the epidermis from the inside. It is particularly indicated for two therapeutic areas: skin affected by various factors such as surface aggressions in post-scarring phase, irritations from cold weather, dryness, wind or pollution, surface acne scars and solar erythmas, and secondly, aggravated skin after certain kinds of cosmetic treatments such as laser treatment, peelings, hair removal, shaving, tattoos or post UVA treatment.  Due to its broad range of indications this cosmetic product can be used throughout the whole year.

Blastoactiva cream has been tested dermatologically and is well-tolerated by the skin and well-accepted by users.  

With this new launch, Almirall further increases its range of skin products. It already has another solution on the market for the care of damaged skin, Blastoestimulina, which is an anti-bacterial cicatrising and regenerating cream also with a centella asiatica base.

 

About Almirall

For further information please visit the website at: www.blastoactiva.es